MITA News

  • MITA News

    Should Medicare beneficiaries have access to the same testing benefits as individuals with private health insurance? That question is at the crux of Medicare’s deliberation of a coverage decision for imaging high risk beneficiaries for lung cancer. – See more at: http://www.diagnosticimaging.com/low-dose/low-dose-lung-ct-can-save-thousands-lives-right-now#sthash.jmHFLUYO.dpuf

  • MITA News

    In an effort to reduce unnecessary care and waste in the health care system, researchers from Harvard Medical School Department of Health Care Policy went after certain tests and procedures that Medicare beneficiaries receive which, according to empirical studies, have been shown to offer little or no health benefit.

  • MITA News

    According to a recent report from the American Cancer Society, cancer survival rates in the United States are climbing. While this welcome trend is a result of a combination of scientific, technological and medical advances, there is no doubt that innovations in medical imaging and radiation therapy technologies play a critical role in the fight against cancer.

  • MITA News

    A Medicare advisory panel voted “low confidence” on the benefits of low-dose computed tomography for lung cancer screening at an April 30 meeting in Baltimore, Md. The Medicare Evidence Development & Coverage Advisory Committee voted “low confidence” on the benefits of low-dose computed tomography for lung cancer screening outweighing any risks posed by CT screening for the disease.

  • MITA News

    The American College of Radiology (ACR) and the Medical Imaging and Technology Alliance (MITA) are weighing in on a negative vote by a Medicare advisory committee regarding coverage of low-dose CT (LDCT) for lung cancer screening.

  • MITA News

    Before January 2016, an estimated one-third of the outpatient installed CT base will need to be replaced if providers wish to avoid the 5% penalty Medicare will levy on scans acquired with outdated CT technology.

  • MITA News

    Imaging has contributed to significant advances in healthcare delivery, leading to better health outcomes and reduced costs. Technology that was once unimaginable is now the medical standard of care. But that is just the tip of the iceberg. The next generation of imaging technologies will not only detect the location of a tumor, it will provide details about the molecular structure of the abnormal tissue within a single scan. In other words, imaging has not just obviated the need for exploratory surgery — it may also soon render biopsies obsolete.

  • MITA News

    The Medical Imaging and Technology Alliance (MITA) also applauded the committee leadership for the deal.

  • MITA News

    “We believe that if colonography is approved for coverage and reimbursement that we will be able to increase the percentage of folks who get screened,” Gail Rodriguez, executive director of MITA, told DOTmed News. “There’s a large number of people today who don’t get the recommended screening and we think that with this test, which is just as sensitive as colonoscopy, a lot more people will be screened and live longer.”

  • MITA News

    Supporters of PET amyloid imaging said they will continue to fight for coverage. “We are committed to working with the Centers for Medicare & Medicaid Services and other experts to generate additional clinical evidence to support coverage for beta amyloid PET for Medicare beneficiaries in the United States,” said Gail Rodriguez, executive director of MITA.